Organigram plans for launch of dried powder
formulation beverage products in early 2020 in Canada
- Proprietary nano-emulsion technology, developed based on
analytical testing, used to create products with an initial onset
of 10-15 minutes
- Shelf-stable, thermally-stable, water-compatible and
palatable cannabinoid nano-emulsion formulation allows for the
production of both liquid and powdered beverage products
- Company actively seeking experienced beverage partner for
global product development
In anticipation of the legalization of adult use recreational
cannabis edibles in Canada, as well as consumer demand for
cannabis-infused beverages, Organigram Holdings Inc. (TSX VENTURE:
OGI) (NASDAQ: OGI), the parent company of Organigram Inc. (the
“Company” or “Organigram”), a leading licensed producer of
cannabis, has developed a proprietary nano-emulsification
technology that will allow for the production of both liquid and
powdered cannabinoid products.
In addition to the Company’s previously announced plans to
launch a range of premium cannabinoid-infused chocolates,
Organigram is planning to launch a variety of dried powder
formulation beverage products in early 2020 in Canada.
“This is an exciting time for cannabis product development, says
Greg Engel, CEO, Organigram. “We know that predictability and
reliability are important to adult consumers of cannabinoid-infused
products. We also believe that a powder additive will offer
consumers a unique and differentiated offering, along with
convenience and discretion. Allowing consumers to make their own
choice as to which beverage they will infuse opens up a new
consumption experience for Canadian cannabis consumers.”
A key anticipated feature of the products to be developed by
Organigram is the initial onset of the effects of the cannabinoids
within 10 to 15 minutes. To determine the onset of effects, the
cannabinoid particles have been studied at a size of 20 nm
(nanometers). Organigram, subject to the receipt of any required
approvals, plans to conduct further testing to confirm the onset of
action and duration of effect.
At the same time, the Company is also actively seeking a
strategic partner with proven experience in beverage product
development to take advantage of the liquid formulation it has
developed.
About Nano-Emulsion
Typically, the active ingredients in cannabis such as
Tetrahydrocannabinol (THC) and Cannabidiol (CBD) are lipophilic,
and don’t naturally dissolve in water. The process by which the
body processes these ingredients can take a significant amount of
time and likely delay the onset and offset of the effects of the
cannabinoids.
“In order to reliably speed up this onset/offset process,
nano-emulsification of these fatty substances into very small water
soluble droplets enables them to be dispersed uniformly in water,”
says Dr. Alec Zhou, Director of Research and Development,
Organigram. “This process effectively bypasses a large part of the
metabolic process, accelerating absorption of active forms of the
cannabinoids into the bloodstream.”
The emulsion process developed by the Organigram team generates
micro-droplets that are very small and uniform, translating to an
absorption and onset of effect that is rapid, reliable and
controlled.
“With traditional edibles and beverages, the body spends
significant time breaking down fat soluble cannabinoid particles
which are then absorbed and metabolized in the body before effects
are felt. This lengthy process can result in accidental
overconsumption and undesirable experiences,” says Ray Gracewood,
Senior Vice President of Marketing and Communications,
Organigram.
“We thought that if we can do that breakdown work before a
consumer ingests the product, these products could have the
potential to change the way consumers think about cannabis-infused
products.”
Organigram’s nano-emulsion technology is stable to temperature
variations, mechanical disturbance, salinity, pH, and
sweeteners.
About Organigram’s Dried Powder Formulation
Organigram researchers have also recently developed a way to
transform this emulsification system into a solid form, turning it
into a dissolvable powder. This shelf-stable, thermally-stable,
water-compatible and palatable cannabinoid nano-emulsion
formulation is expected to provide an initial onset of effect
within 10 to 15 minutes if used in a beverage.
The powdered formulation will offer consumers a measured dose of
cannabinoids which they can then add to the beverage of their
choice and expect a reliably rapid onset and offset of effects,
while also offering the discretion, portability and shelf life
expected of a dry formulation.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX
Venture Exchange listed company whose wholly owned subsidiary,
Organigram Inc., is a licensed producer of cannabis and
cannabis-derived products in Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and
Trailblazer. Organigram's primary facility is located in Moncton,
New Brunswick and the Company is regulated by the Cannabis Act and
the Cannabis Regulations (Canada).
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release.
Examples of such statements include statements with respect to
variety and timing of product development including dried powder
beverage formulations and the attributes thereof and timing for
further testing and the receipt of any required license or approval
to do so. Risks, uncertainties and other factors involved with
forward-looking information could cause actual events, results,
performance, prospects and opportunities to differ materially from
those expressed or implied by such forward-looking information
include results of testing, unforeseen delays in steps related to
product testing and development; including risks as disclosed in
the Company’s most recent annual information form, management’s
discussion and analysis and other Company documents filed from time
to time on SEDAR (see www.sedar.com). Readers are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date of this press release. Although the
Company believes that the assumptions and factors used in preparing
the forward-looking information in this news release are
reasonable, undue reliance should not be placed on such information
and no assurance can be given that such events will occur in the
disclosed time frames or at all. The forward-looking information
included in this news release are made as of the date of this news
release and the Company disclaims any intention or obligation,
except to the extent required by law, to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise. We seek safe harbor.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190708005624/en/
For Investor Relations enquiries: Amy Schwalm Vice President,
Investor Relations Amy.Schwalm@organigram.ca (416) 704-9057
For Media enquiries: Ray Gracewood
Senior Vice President, Marketing and Communications
rgracewood@organigram.ca (506) 645-1653
OrganiGram (TSX:OGI)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
OrganiGram (TSX:OGI)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
